Is overall asthma control being achieved? A hypothesis-generating study.
暂无分享,去创建一个
[1] R. Pauwels,et al. GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .
[2] A. Buist,et al. Association of asthma control with health care utilization and quality of life. , 1999, American journal of respiratory and critical care medicine.
[3] A. Buist,et al. Validation of a standardized version of the Asthma Quality of Life Questionnaire. , 1999, Chest.
[4] W. Lumry,et al. Combined Salmeterol 50 μ g and Fluticasone Propionate 250 μ g in the Diskus Device for the Treatment of Asthma , 2000 .
[5] Alfred O. Berg,et al. Clinical Guidelines And Primary Care Guidelines For The Diagnosis And Management Of Asthma , 2012 .
[6] C. Jenkins,et al. Optimal asthma control, starting with high doses of inhaled budesonide. , 2000, The European respiratory journal.
[7] M. Kavuru,et al. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial. , 2000, The Journal of allergy and clinical immunology.
[8] C. Jenkins,et al. Salmeterol/fluticasone propionate combination therapy 50/250 microg twice daily is more effective than budesonide 800 microg twice daily in treating moderate to severe asthma. , 2000, Respiratory medicine.
[9] V. Backer,et al. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers. , 1999, Canadian respiratory journal.
[10] A. Buist. Guidelines for the management of chronic obstructive pulmonary disease. , 2002, Respiratory medicine.
[11] G H Guyatt,et al. Development and validation of a questionnaire to measure asthma control. , 1999, The European respiratory journal.
[12] M. Aubier,et al. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma. , 1999, Respiratory medicine.
[13] D. Cockcroft,et al. Asthma control versus asthma severity. , 1996, The Journal of allergy and clinical immunology.
[14] J Zhang,et al. What are minimal important changes for asthma measures in a clinical trial? , 1999, The European respiratory journal.
[15] E. Bateman,et al. Salmeterol/Fluticasone Combination Inhaler , 1998, Clinical drug investigation.
[16] S. Leeder,et al. The asthma health outcome indicators study , 1996, Australian and New Zealand journal of public health.
[17] E. Juniper,et al. Measuring asthma control. Clinic questionnaire or daily diary? , 2000, American journal of respiratory and critical care medicine.
[18] H. Anttila,et al. Salmeterol/fluticasone propionate (50/100 μg) in combination in a Diskus™ inhaler (Seretide™) is effective and safe in children with asthma , 2000, Pediatric pulmonology.
[19] Lynn Wei,et al. Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic Asthma , 1999, Annals of Internal Medicine.